A federal investigation into the death of Indianapolis Colts owner Jim Irsay is shedding light on potentially improper medical practices, raising concerns about prescription abuse and celebrity treatment ethics.
Story Highlights
- FBI investigates the death of Jim Irsay, former owner of the Indianapolis Colts.
- Focus on the relationship with Dr. Harry Haroutunian and prescription practices.
- Scrutiny over the lack of an autopsy and potential prescription misuse.
- Parallels are drawn with similar high-profile cases in the opioid crisis.
Federal Probe into Irsay’s Death
The FBI has launched an investigation into the May 2025 death of former Indianapolis Colts owner Jim Irsay, focusing on his substance use and relationship with California addiction specialist Dr. Harry Haroutunian.
The investigation aims to clarify the circumstances surrounding Irsay’s death, which occurred in a Beverly Hills hotel, and examine the prescribing practices of Dr. Haroutunian, who signed the death certificate listing cardiac arrest due to pneumonia without conducting an autopsy.
Irsay, well-known for his battles with substance abuse, had been receiving treatment from Dr. Haroutunian, who prescribed him over 200 opioid pills prior to his December 2023 death.
This relationship is now under scrutiny amid a grand jury subpoena issued in Los Angeles. The investigation draws parallels with other high-profile cases, such as Matthew Perry’s 2023 ketamine-related death, where legal issues surrounding prescription practices came to the forefront.
Potential Implications and Stakeholders
The implications of this investigation extend beyond the Irsay family and the Colts organization. It raises questions about the ethical responsibilities of addiction specialists and the oversight of prescription practices.
The NFL could see shifts in policies regarding owner health and addiction, as the probe highlights the ongoing challenges of substance abuse within high-profile circles.
The FBI is investigating the death of former Colts owner Jim Irsay
The same doctor accused of supplying him with massive amounts of opioids and ketamine also signed the death certificate and ruled it a “natural” death per @washingtonpost pic.twitter.com/Eb9R8d4ekt
— Bussin' With The Boys (@BussinWTB) January 22, 2026
Jim Irsay’s daughters, Carlie Irsay-Gordon, Casey Foyt, and Kalen Jackson, have taken over ownership of the Colts. They face the daunting task of managing the team amid growing public scrutiny and potential disruptions from subpoenas. The Colts have not been contacted by the FBI, but the legal team is prepared to manage any developments that could impact the franchise’s operations.
Broader Context and Industry Impact
The investigation underscores the broader issue of the opioid crisis in America, particularly how it affects individuals in positions of power and influence. The focus on ketamine and opioid prescriptions in Irsay’s case reflects the ongoing national debate about the regulation of addictive substances and the accountability of medical professionals.
Death of Indianapolis Colts owner Jim Irsay under federal investigation: Sources https://t.co/6WbQWz88QE
— ABC13 Houston (@abc13houston) January 24, 2026
As the investigation unfolds, stakeholders across the NFL and the addiction treatment industry will be closely monitoring developments. The outcome could lead to significant changes in how addiction is treated in high-profile cases and might prompt stricter regulations on prescription practices, aiming to prevent further tragedies in the realm of professional sports and beyond.
Sources:
Colts confirm FBI investigating death of former owner Jim Irsay
Death of Colts owner Jim Irsay now federal investigation
